David J. Zammit

1.8k total citations
17 papers, 1.5k citations indexed

About

David J. Zammit is a scholar working on Immunology, Dermatology and Oncology. According to data from OpenAlex, David J. Zammit has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Dermatology and 3 papers in Oncology. Recurrent topics in David J. Zammit's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (6 papers). David J. Zammit is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (6 papers). David J. Zammit collaborates with scholars based in United States, Canada and Australia. David J. Zammit's co-authors include Leo Lefrançois, Linda S. Cauley, Quynh-Mai Pham, Yi Yang, Jie Dai, Bei Liu, Zihai Li, Pramod K. Srivastava, Kimberly D. Klonowski and Damian Turner and has published in prestigious journals such as Immunity, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

David J. Zammit

17 papers receiving 1.4k citations

Peers

Countries citing papers authored by David J. Zammit

Since Specialization

Citations

This map shows the geographic impact of David J. Zammit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Zammit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Zammit more than expected).

Fields of papers citing papers by David J. Zammit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Zammit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Zammit. The network helps show where David J. Zammit may publish in the future.

Co-authorship network of co-authors of David J. Zammit

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Zammit. A scholar is included among the top collaborators of David J. Zammit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Zammit. David J. Zammit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study 2023 ·Journal of the American Academy of Dermatology ·Pablo A. Jimenez, Howard Sofen, Robert Bissonnette, Mark Lee, Joseph F. Fowler, David J. Zammit, Yusong Chen, Niranjan Rao, Louis Denis, Sandeep Kumar Gupta	25
2	ASN004, A 5T4-targeting scFv-Fc Antibody–Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models 2021 ·Molecular Cancer Therapeutics ·Roger A. Smith, David J. Zammit, Nitin K. Damle, Helen Usansky, Sanjeeva Reddy, Jun-Hsiang Lin, Mahesh Mistry, Niranjan Rao, Louis Denis, (unknown)	19
3	The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study 2019 ·British Journal of Dermatology ·Robert Bissonnette, Catherine Maari, Seth Forman, Neal Bhatia, (unknown), Joseph F. Fowler, Stephen K. Tyring, David M. Pariser, Howard Sofen, Sunil Dhawan, (unknown), David J. Zammit, Helen Usansky, L. Denis, Niranjan Rao, Teresa Song, Ana B. Pavel, Emma Guttman‐Yassky	101
4	Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis 2019 ·Journal of Allergy and Clinical Immunology ·Ana B. Pavel, Teresa Song, Hyun Je Kim, Ester Del Duca, James G. Krueger, Celina Dubin, Xiangyu Peng, Hui Xu, Ning Zhang, Yeriel Estrada, Louis Denis, Niranjan Rao, (unknown), David J. Zammit, Robert Bissonnette, Emma Guttman‐Yassky	110
5	559 ASN002 a dual oral inhibitor of JAK/SYK signaling improves clinical outcomes and associated cutaneous inflammation in moderate-to-severe atopic dermatitis patients 2018 ·Journal of Investigative Dermatology ·Emma Guttman‐Yassky, Ana B. Pavel, Teresa Song, (unknown), David J. Zammit, (unknown), Niranjan Rao	10
6	Abstract B109: ASN004, a novel 5T4-targeted Dolaflexin ADC, causes complete and durable tumor regression in a variety of tumor xenograft models 2018 ·Molecular Cancer Therapeutics ·Roger A. Smith, David J. Zammit, Sanjeeva Reddy	2
7	Abstract 4204: ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity in both hematological and solid tumor xenograft models 2017 ·Cancer Research ·Sanjeeva Reddy, Niranjan Rao, David J. Zammit, Scott K. Thompson, Roger A. Smith, Louis Denis	5
8	Pro‐inflammatory role of natural killer cells in the development of allergic airway disease 2014 ·Clinical & Experimental Allergy ·Clinton B. Mathias, (unknown), David J. Zammit, (unknown), Carol A. Wu, Roger S. Thrall, Héctor L. Aguila	36
9	Heat Shock Protein gp96 Is a Master Chaperone for Toll-like Receptors and Is Important in the Innate Function of Macrophages 2007 ·Immunity ·Yi Yang, Bei Liu, Jie Dai, Pramod K. Srivastava, David J. Zammit, Leo Lefrançois, Zihai Li	374
10	The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells 2007 ·The Journal of Immunology ·Jeremy P. McAleer, David J. Zammit, Leo Lefrançois, Robert J. Rossi, Anthony T. Vella	33
11	Steady State Dendritic Cells Present Parenchymal Self-Antigen and Contribute to, but Are Not Essential for, Tolerization of Naive and Th1 Effector CD4 Cells 2007 ·The Journal of Immunology ·Adam T. Hagymasi, (unknown), Marianne A. Mihalyo, (unknown), David J. Zammit, Leo Lefrançois, Adam J. Adler	15
12	Dendritic cell–T cell interactions in the generation and maintenance of CD8 T cell memory 2006 ·Microbes and Infection ·David J. Zammit, Leo Lefrançois	13
13	Residual Antigen Presentation after Influenza Virus Infection Affects CD8 T Cell Activation and Migration 2006 ·Immunity ·David J. Zammit, Damian Turner, Kimberly D. Klonowski, Leo Lefrançois, Linda S. Cauley	211
14	CCR6-Mediated Dendritic Cell Activation of Pathogen-Specific T Cells in Peyer's Patches 2006 ·Immunity ·(unknown), Jan Hendrik Niess, David J. Zammit, Rajesh Ravindran, Aparna Srinivasan, Joseph R. Maxwell, Thomas A. Stoklasek, Rajwardhan Yadav, Ifor R. Williams, Xiubin Gu, Beth A. McCormick, Michael A. Pazos, Anthony T. Vella, Leo Lefrançois, Hans-Christian Reinecker, Stephen J. McSorley	194
15	Effects of LPS-mediated bystander activation in the innate immune system 2006 ·Journal of Leukocyte Biology ·Rajwardhan Yadav, David J. Zammit, Leo Lefrançois, Anthony T. Vella	25
16	Dendritic Cells Maximize the Memory CD8 T Cell Response to Infection 2005 ·Immunity ·David J. Zammit, Linda S. Cauley, Quynh-Mai Pham, Leo Lefrançois	275
17	Essential Role for the Lymphostromal Plasma Membrane Ly-6 Superfamily Molecule Thymic Shared Antigen 1 in Development of the Embryonic Adrenal Gland 2002 ·Molecular and Cellular Biology ·David J. Zammit, Stuart P. Berzins, Jason Gill, (unknown), Louise Barnett, Frank Köentgen, Gavin Lambert, Richard P. Harvey, Richard L. Boyd, Brendan J. Classon	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact